In a bold move that could revolutionize the pharmaceutical industry, leading Silicon Valley players …
drug development
-
-
AI Development in HealthcareData Privacy & SecurityGenetic Testing IndustryHealthcare & Pharmaceuticals
23andMe and its customers’ data sold to US pharma giant
by Lila Hernandez 2 minutes readIn a recent development that has stirred the digital health community, 23andMe, the popular …
-
Genetic Testing IndustryHealthcare & PharmaceuticalsHealthcare Technology
Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
by Nia Walkerby Nia Walker 2 minutes readTitle: Regeneron’s Strategic Move: Acquiring 23andMe and Its Wealth of Genetic Data In a …
-
BiotechnologyHealthcare & Pharmaceuticals
Ignota Labs: Turning around failed drugs using AI
by Lila Hernandez 2 minutes readIn the dynamic world of biotechnology, Ignota Labs emerges as a beacon of innovation, …
-
Healthcare & Pharmaceuticals
Shaileshbhai Kaklotar: The Scientist Transforming Drug Access and Regulatory Innovation in America
by Lila Hernandez 2 minutes readIn an era defined by urgency in healthcare and relentless scientific innovation, Shaileshbhai Kaklotar, …
-
3D printing technologyAI InnovationEntrepreneurshipHealthcare & Pharmaceuticals
Presentation: Data, Drugs, and Disruption: Leading High-performance Company in Drug Development
by Samantha Rowland 2 minutes readUnlocking Success in Drug Development: A Journey from Data to Disruption As the tech …
-
BioinformaticsBiotechnologyHealthcare and PharmaceuticalsMaterials Science
Microsoft Releases BioEmu-1: A Deep Learning Model for Protein Structure Prediction
by Samantha Rowland 2 minutes readMicrosoft has recently unveiled BioEmu-1, a cutting-edge deep learning model engineered to revolutionize protein …
-
Artificial IntelligenceBiotechnologyDrug Discovery
How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech
by Samantha Rowland 2 minutes readIn a remarkable tale of innovation and perseverance, Crystal Brown, an automotive executive, shifted …
-
BiotechnologyPharmaceuticals
Neumirna raises €20m, will begin clinical trials for its epilepsy drug
by David Mitchell 2 minutes readNeumirna Secures €20m Funding for Epilepsy Drug Clinical Trials The landscape of biotechnology is …